SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
BioChemics, Inc. Announces Positive Phase 2 Data for a Novel Transdermal Ibuprofen Drug Formulation Developed to Treat Osteoarthritis